Epigenetic deregulation of GATA3 in neuroblastoma is associated with increased GATA3 protein expression and with poor outcomes
Open Access
- 12 December 2019
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-12
Abstract
To discover epigenetic changes that may underly neuroblastoma pathogenesis, we identified differentially methylated genes in neuroblastoma cells compared to neural crest cells, the presumptive precursors cells for neuroblastoma, by using genome-wide DNA methylation analysis. We previously described genes that were hypermethylated in neuroblastoma; in this paper we report on 67 hypomethylated genes, which were filtered to select genes that showed transcriptional over-expression and an association with poor prognosis in neuroblastoma, highlighting GATA3 for detailed studies. Specific methylation assays confirmed the hypomethylation of GATA3 in neuroblastoma, which correlated with high expression at both the RNA and protein level. Demethylation with azacytidine in cultured sympathetic ganglia cells led to increased GATA3 expression, suggesting a mechanistic link between GATA3 expression and DNA methylation. Neuroblastomas that had completely absent GATA3 methylation and/or very high levels of protein expression, were associated with poor prognosis. Knock-down of GATA3 in neuroblastoma cells lines inhibited cell proliferation and increased apoptosis but had no effect on cellular differentiation. These results identify GATA3 as an epigenetically regulated component of the neuroblastoma transcriptional control network, that is essential for neuroblastoma proliferation. This suggests that the GATA3 transcriptional network is a promising target for novel neuroblastoma therapies.Keywords
Funding Information
- King Saud University
- Fonds National de la Recherche Luxembourg
This publication has 59 references indexed in Scilit:
- Epigenetic regulation of neuroblastoma developmentCell and tissue research, 2018
- GATA3 is a reliable marker for neuroblastoma in limited samples, including FNA Cell Blocks, core biopsies, and touch imprintsCancer Cytopathology, 2017
- Genome‐wide DNA methylation analysis identifies MEGF10 as a novel epigenetically repressed candidate tumor suppressor gene in neuroblastomaMolecular Carcinogenesis, 2016
- Cyclin D1 in pediatric neuroblastic tumors: A microarray analysisActa Histochemica, 2015
- TGFBR3 Co‐Downregulated With GATA3 Is Associated With Methylation of the GATA3 Gene in Bladder Urothelial CarcinomaThe Anatomical Record, 2013
- MYCN is recruited to the RASSF1A promoter but is not critical for DNA hypermethylation in neuroblastomaMolecular Carcinogenesis, 2012
- The Connections Between Neural Crest Development and Neuroblastoma2011
- Genome‐wide DNA methylation analysis of neuroblastic tumors reveals clinically relevant epigenetic events and large‐scale epigenomic alterations localized to telomeric regionsInternational Journal of Cancer, 2010
- Aberrant methylation of candidate tumor suppressor genes in neuroblastomaCancer Letters, 2008
- Phox2B mutations and the Delta–Notch pathway in neuroblastomaCancer Letters, 2005